Illumina faces EU gun-jumping probe over Grail acquisition
The European Commission has opened a gun-jumping investigation into Illumina, two days after the biotechnology company completed its acquisition of Grail in the midst of the EU’s in-depth merger review.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.